Can childhood blood cancer be cured? What parents need to know
Almost all children, about 98 per cent, go into remission after initial treatment, and more than 90 per cent are alive and disease-free five years later, which doctors treat as a strong proxy for cure
Childhood leukaemia is now a significant success story in modern medicine, with cure rates for Acute lymphoblastic leukaemia (ALL) reaching approximately 90%. This remarkable improvement, driven by advancements in chemotherapy and collaborative research, contrasts sharply with historical survival rates
Childhood leukaemia is now a significant success story in modern medicine, with cure rates for Acute lymphoblastic leukaemia (ALL) reaching approximately 90%. This remarkable improvement, driven by advancements in chemotherapy and collaborative research, contrasts sharply with historical survival rates
Childhood leukaemia is now a significant success story in modern medicine, with cure rates for Acute lymphoblastic leukaemia (ALL) reaching approximately 90%. This remarkable improvement, driven by advancements in chemotherapy and collaborative research, contrasts sharply with historical survival rates
If your child has just been diagnosed with leukaemia, the word 'cancer' can feel like a door slamming shut on the future. But blood cancers in children are, quietly, one of modern medicine's biggest success stories and the honest answer to whether they're curable is: in most cases, yes.
Start with the most common one. Acute lymphoblastic leukaemia (ALL) makes up around 75-80 per cent of childhood leukaemias, and it's now cured in roughly 90 per cent of children. Almost all children, about 98 per cent, go into remission after initial treatment, and more than 90 per cent are alive and disease-free five years later, which doctors treat as a strong proxy for cure.
This wasn't always the case: back in the 1960s, only around 14 per cent of children with ALL survived even five years. Decades of combination chemotherapy, better risk-stratification, and international clinical trial collaborations turned a near-certain death sentence into a largely beatable disease.
Acute myeloid leukaemia (AML) is tougher — it's less common but more aggressive — with 5-year survival around 65-70 per cent overall, and children with favorable genetic subtypes doing considerably better, often 70-80 per cent cured with chemotherapy alone.
Age matters too. Children aged 5-9 tend to have the best outcomes, around 93-94 per cent survival, while teenagers 15-19 see a noticeable dip to 74-76 per cent, because their leukaemia biology behaves more like adult disease.
There's an important caveat: these numbers largely reflect children treated in well-resourced health systems. In high-income countries, cure rates exceed 80 per cent; in lower-resourced settings, they can fall well below 30 per cent, mainly because of delayed diagnosis, limited access to pediatric oncology centers, and treatment interruptions—a gap global health experts increasingly call a solvable problem, not an inevitable one.
The bottom line: a childhood blood cancer diagnosis is frightening, but it's no longer the tragedy it once was. With early diagnosis and access to modern treatment, most children don't just survive — they go on to live full, healthy lives.
(The author is a consultant in paediatric haematology and oncology at Manipal Hospital Varthur and Whitefield)
The opinions expressed in this article are those of the author and do not purport to reflect the opinions or views of THE WEEK.